Evonik Rexim Nanning Pharmaceutical Co., Ltd.
FDA inspection history in Wuming District, China, 2018
- 1
- Form 483
Every document, by year
- Form 483
2018: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2018One Form 483, at Wuming District, China.
Cited most
Across all Evonik Rexim Nanning Pharmaceutical Co. observations on file
- 21 CFR 211.63Equipment design, size, and location1
- 21 CFR 211.68Automatic, mechanical, and electronic equipment1
The complete Evonik Rexim Nanning Pharmaceutical Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Wuming District, China
One Form 483 · 2018 · 1 observation
Latest: Form 483, Sep 28, 2018 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2018-09-28 | 483 Form 483 | Wuming District, China | 1 | $99 |
Investigators on these documents
About Evonik Rexim Nanning Pharmaceutical Co., Ltd.
How many FDA Form 483s has Evonik Rexim Nanning Pharmaceutical Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Evonik Rexim Nanning Pharmaceutical Co., Ltd.; the most recent is dated Sep 28, 2018.
When was Evonik Rexim Nanning Pharmaceutical Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Evonik Rexim Nanning Pharmaceutical Co., Ltd. is a Form 483 dated Sep 28, 2018, for the site in Wuming District, China.
What did FDA cite at Evonik Rexim Nanning Pharmaceutical Co., Ltd.?
The regulations cited most in the observations on file for Evonik Rexim Nanning Pharmaceutical Co., Ltd. are 21 CFR 211.63 (Equipment design, size, and location), 1 time; 21 CFR 211.68 (Automatic, mechanical, and electronic equipment), 1 time.